The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 May 28

PMID 34046336

Citations 4

Authors

Natalya Apanovich

Pavel Apanovich

Danzan Mansorunov

Anna Kuzevanova

Vsevolod Matveev

Alexander Karpukhin

Affiliations

Soon will be listed here.

Abstract

We aimed to identify and investigate genes that are essential for the development of clear cell renal cell carcinoma (ccRCC) and sought to shed light on the mechanisms of its progression and create prognostic markers for the disease. We used real-time PCR to study the expression of 20 genes that were preliminarily selected based on their differential expression in ccRCC, in 68 paired tumor/normal samples. Upon ccRCC progression, seven genes that showed an initial increase in expression showed decreased expression. The genes whose expression levels did not significantly change during progression were associated mainly with metabolic and inflammatory processes. The first group included , , , , , , and , whose expression levels were coordinately decreased during tumor progression. This expression coordination and gene function is related to the needs of tumor development at different stages. Specifically, the high correlation coefficient of and expression may indicate the importance of the coordinated regulation of glycolysis and mitochondrial metabolism. A panel of , , , and enabled the prediction of survival for more than 3.5 years in patients with ccRCC, with a probability close to 90%. Therefore, a coordinated change in the expression of a gene group during ccRCC progression was detected, and a new panel of markers for individual survival prognosis was identified.

Citing Articles

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target.

Li Y, Zhang Y, Cao M, Yuan T, Ou S Front Pharmacol. 2025; 15():1475198.

PMID: 39840089 PMC: 11747783. DOI: 10.3389/fphar.2024.1475198.

BHLHE41, a transcriptional repressor involved in physiological processes and tumor development.

Bret C, Desmots-Loyer F, Moreaux J, Fest T Cell Oncol (Dordr). 2024; 48(1):43-66.

PMID: 39254779 PMC: 11850569. DOI: 10.1007/s13402-024-00973-3.

NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2.

Wang D, Zhang P, Liu Z, Xing Y, Xiao Y Cancers (Basel). 2022; 14(15).

PMID: 35954445 PMC: 9367313. DOI: 10.3390/cancers14153782.

The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.

Strocchi S, Reggiani F, Gobbi G, Ciarrocchi A, Sancisi V Oncogene. 2022; 41(29):3665-3679.

PMID: 35705735 DOI: 10.1038/s41388-022-02378-8.

Panel of Candidate Genes to Predict the Survival of Patients with Clear Cell Renal Cancer on the Basis of Gene Expression Regulated by HIF1α/HIF2α.

Apanovich N, Apanovich P, Mansorunov D, Kuzevanova A, Korotaeva A, Bogush T Bull Exp Biol Med. 2022; 172(6):738-742.

PMID: 35501649 DOI: 10.1007/s10517-022-05468-5.

References

Goel M, Khanna P, Kishore J . Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2011; 1(4):274-8. PMC: 3059453. DOI: 10.4103/0974-7788.76794. View

Jager K, van Dijk P, Zoccali C, Dekker F . The analysis of survival data: the Kaplan-Meier method. Kidney Int. 2008; 74(5):560-5. DOI: 10.1038/ki.2008.217. View

Bigot P, Colli L, Machiela M, Jessop L, Myers T, Carrouget J . Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41. Nat Commun. 2016; 7:12098. PMC: 4941055. DOI: 10.1038/ncomms12098. View

Kaluz S, Kaluzova M, Liao S, Lerman M, Stanbridge E . Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?. Biochim Biophys Acta. 2009; 1795(2):162-72. PMC: 2670353. DOI: 10.1016/j.bbcan.2009.01.001. View

Shi S, Qin X, Wang S, Wang W, Zhu Y, Lin Y . Identification of potential novel differentially-expressed genes and their role in invasion and migration in renal cell carcinoma. Aging (Albany NY). 2020; 12(10):9205-9223. PMC: 7288970. DOI: 10.18632/aging.103192. View

Franchini M, Frattini F, Crestani S, Bonfanti C, Lippi G . von Willebrand factor and cancer: a renewed interest. Thromb Res. 2013; 131(4):290-2. DOI: 10.1016/j.thromres.2013.01.015. View

Mojiri A, Stoletov K, Lorenzana Carrillo M, Willetts L, Jain S, Godbout R . Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin. Oncotarget. 2016; 8(8):13015-13029. PMC: 5355073. DOI: 10.18632/oncotarget.14273. View

Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P . External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Eur Urol. 2008; 57(1):102-9. DOI: 10.1016/j.eururo.2008.11.033. View

Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H, Kato Y . Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem. 2002; 277(49):47014-21. DOI: 10.1074/jbc.M204938200. View

10.

Lim M, Wee J, Soong J, Chua D, Tan W, Lizwan M . Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs. Mol Cancer. 2018; 17(1):152. PMC: 6195749. DOI: 10.1186/s12943-018-0904-z. View

11.

Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E . SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012; 487(7407):380-4. DOI: 10.1038/nature11207. View

12.

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

13.

Asanoma K, Liu G, Yamane T, Miyanari Y, Takao T, Yagi H . Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells. Mol Cell Biol. 2015; 35(24):4096-109. PMC: 4648814. DOI: 10.1128/MCB.00678-15. View

14.

Zhang T, Niu X, Liao L, Cho E, Yang H . The contributions of HIF-target genes to tumor growth in RCC. PLoS One. 2013; 8(11):e80544. PMC: 3832366. DOI: 10.1371/journal.pone.0080544. View

15.

Zhang Z, Lin E, Zhuang H, Xie L, Feng X, Liu J . Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. Cancer Cell Int. 2020; 20:27. PMC: 6986036. DOI: 10.1186/s12935-020-1113-6. View

16.

Moein S, Javanmard S, Abedi M, Izadpanahi M, Gheisari Y . Identification of Appropriate Housekeeping Genes for Gene Expression Analysis in Long-term Hypoxia-treated Kidney Cells. Adv Biomed Res. 2017; 6:15. PMC: 5343613. DOI: 10.4103/2277-9175.200790. View

17.

Belfiore A . New insights on the Intrinsic, Pro-Apoptotic Effect of IGFB3 in Breast Cancer. Front Endocrinol (Lausanne). 2014; 5:176. PMC: 4204635. DOI: 10.3389/fendo.2014.00176. View

18.

Mochizuki S, Soejima K, Shimoda M, Abe H, Sasaki A, Okano H . Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. J Natl Cancer Inst. 2012; 104(12):906-22. DOI: 10.1093/jnci/djs232. View

19.

Shen C, Liu J, Wang J, Zhong X, Dong D, Yang X . Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. Int Immunopharmacol. 2020; 81:106274. DOI: 10.1016/j.intimp.2020.106274. View

20.

Mezouar S, Frere C, Darbousset R, Mege D, Crescence L, Dignat-George F . Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences. Thromb Res. 2016; 139:65-76. DOI: 10.1016/j.thromres.2016.01.006. View